CVRx, Inc. (CVRX) Stock Ticker
CVRX right now
Market factors today
Unlock the full CVRX picture
About CVRx, Inc.
CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure. The company employs a diverse distribution strategy, leveraging its internal sales force, alongside sales agents and independent distributors, to reach markets across the United States, Germany, the wider European continent, and other global territories. Incorporated in 2000, CVRx, Inc. is headquartered in Minneapolis, Minnesota.
CVRX stock facts
| Ticker symbol | CVRX |
| Exchange | NASDAQ Global Select |
| Sector | Healthcare |
| Industry | Medical - Devices |
| Market cap | $71.6M |
| CEO | Kevin Hykes |
| Employees | 223 |
| Headquarters | Minneapolis, MN, US |
| IPO date | 2021-06-30 |
| Website | www.barostim.com |
What you can see for CVRX on Tickr
Live CVRX price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the CVRX report.
Rankings
FAQ
What is the ticker symbol for CVRx, Inc.?
The ticker symbol for CVRx, Inc. is CVRX, listed on the NASDAQ Global Select.
What is CVRX?
CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection…